Acta poloniae pharmaceutica 2009-01-01

New derivatives of benzylamide with anticonvulsant activity.

Marzanna Strupińska, Grazyna Rostafińska-Suchar, James P Stables, Ryszard Paruszewski

Index: Acta Pol. Pharm. 66(2) , 155-9, (2009)

Full Text: HTML

Abstract

Previously obtained picolinic acid benzylamide is a potent anticonvulsant with low neurotoxicity. In search for new effective anticonvulsants twelve new benzylamides (1-12) were synthesized and preliminary evaluated in the Anticonvulsant Screening Program (ASP) of Antiepileptic Drug Development Program (ADDP) of NIH. Two of them appeared the most promising: 1-cyclopentenecarboxylic acid benzylamide (1-Cpc-BZA) (9) showed MES ED50 = 85,36 mg/kg (PI = 2,49), scPTZ ED50 = 1,37 mg/kg (PI = 1,37), 6Hz-EST ED50 = 50,29 mg/kg and cyclopentanecarboxylic acid benzylamide (Cpc-BZA) (11) showed pilocarpine ED50 = 154.75 mg/kg and pilocarpine ED97 = 270.95 mg/kg.


Related Compounds

Related Articles:

Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.

2009-09-15

[Bioorg. Med. Chem. Lett. 19(18) , 5334-8, (2009)]

Preparation of cis-Hexahydroindane-8-carboxylic Acid. DAUBEN W, et al.

[J. Org. Chem. 26(2) , 297-300, (1961)]

More Articles...